Jeffrey L. Ives - Net Worth and Insider Trading

Jeffrey L. Ives Net Worth

The estimated net worth of Jeffrey L. Ives is at least $10,182 dollars as of 2024-05-28. Jeffrey L. Ives is the Director of Cara Therapeutics Inc and owns about 15,476 shares of Cara Therapeutics Inc (CARA) stock worth over $10,182. Jeffrey L. Ives is also the Director of Acumen Pharmaceuticals Inc and owns about 0 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $0. Details can be seen in Jeffrey L. Ives's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey L. Ives has not made any transactions after 2023-08-17 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey L. Ives

To

Jeffrey L. Ives Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey L. Ives owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Acumen Pharmaceuticals Inc (ABOS) .

Click here to see the complete history of Jeffrey L. Ives’s form 4 insider trades.

Insider Ownership Summary of Jeffrey L. Ives

Ticker Comapny Transaction Date Type of Owner
CARA Cara Therapeutics Inc 2022-07-15 director
ABOS Acumen Pharmaceuticals Inc 2023-08-17 director

Jeffrey L. Ives Latest Holdings Summary

Jeffrey L. Ives currently owns a total of 2 stocks. Among these stocks, Jeffrey L. Ives owns 15,476 shares of Cara Therapeutics Inc (CARA) as of July 15, 2022, with a value of $10,182 and a weighting of 100%. Jeffrey L. Ives also owns 0 shares of Acumen Pharmaceuticals Inc (ABOS) as of August 17, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Jeffrey L. Ives

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CARA Cara Therapeutics Inc 2022-07-15 15,476 0.66 10,182
ABOS Acumen Pharmaceuticals Inc 2023-08-17 0 3.27 0

Holding Weightings of Jeffrey L. Ives


Jeffrey L. Ives Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey L. Ives has made a total of 16 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 3,600 shares on July 15, 2022, which brought Jeffrey L. Ives around $32,580.

According to the SEC Form 4 filings, Jeffrey L. Ives has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 41,949 shares on August 17, 2023, which brought Jeffrey L. Ives around $272,249.

Insider Trading History of Jeffrey L. Ives

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey L. Ives Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey L. Ives Ownership Network

Ownership Network List of Jeffrey L. Ives

No Data

Ownership Network Relation of Jeffrey L. Ives


Jeffrey L. Ives Owned Company Details

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Jeffrey L. Ives is the director of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Jeffrey L. Ives made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 66,642 shares made by Christopher Posner , a net sale of 29,470 shares made by Joana Goncalves , and a net sale of 24,304 shares made by Scott Terrillion .

In summary, during the past 3 months, insiders sold 9,442 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 9,442 shares. During the past 18 months, 141,938 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 141,938 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cara Therapeutics Inc Insider Transactions

No Available Data

Jeffrey L. Ives Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey L. Ives. You might contact Jeffrey L. Ives via mailing address: C/o Cara Therapeutics, Inc., 1 Parrott Drive, Shelton Ct 06484.

Discussions on Jeffrey L. Ives

No discussions yet.